Postoperative ctDNA Provides Prognostic Value for DFS Outcomes in CRC
Circulating tumor DNA status at the time of postoperative minimal residual disease assessment was found to be a prognostic factor for disease-free survival in patients with radically resected stage II to IV colorectal cancer.
Patients With Radically Resected Stage Ii To Iv Colorectal Cancer Circulate Japan Trial Galaxy Study Jun Watanabe Yokohama City University Medical Center
Source: onclive.com